Related Experiment Video

Updated: Apr 16, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

2.2K

Heterocyclic Scaffolds: Centrality in Anticancer Drug Development

Imran Ali1, Mohammad Nadeem Lone, Zeid A Al-Othman

  • 1Department of Chemistry, Jamia Millia Islamia (Central University), New Delhi-110025, India. drimran.chiral@gmail.com.

Current Drug Targets
|March 10, 2015
PubMed

Insights

Heterocyclic compounds are crucial in developing new anticancer drugs. This review explores their medicinal properties, market applications, and future potential for effective cancer treatments.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Organic Chemistry

Background:

  • Cancer remains a significant global health challenge, with limited treatment options for advanced stages.
  • Existing anticancer drugs often have severe side effects.
  • Heterocyclic compounds have demonstrated potent anticancer properties.

Purpose of the Study:

  • To highlight the importance of heterocyclic nuclei in anticancer drug development.
  • To review naturally occurring and synthetic heterocyclic anticancer agents.
  • To discuss mechanisms of action, market examples, and future directions.

Main Methods:

  • Literature review of heterocyclic compounds in cancer research.
  • Analysis of market-selling heterocyclic anticancer drugs.
  • Discussion of mechanisms of action and recent advances.

Main Results:

  • Heterocyclic moieties are fundamental to many existing and emerging anticancer drugs.
  • Both natural and synthetic heterocyclic compounds show significant anticancer activity.
  • Marketed drugs like 5-fluorouracil and vinblastine exemplify the success of heterocyclic scaffolds.

Conclusions:

  • Heterocyclic compounds are vital for advancing anticancer therapies.
  • Further research into novel heterocyclic agents promises more effective and selective treatments.
  • Future efforts should focus on developing human-friendly anticancer drugs with improved efficacy.

More Related Videos

Efficient Construction of Drug-like Bispirocyclic Scaffolds Via Organocatalytic Cycloadditions of α-Imino γ-Lactones and Alkylidene Pyrazolones10:17

Efficient Construction of Drug-like Bispirocyclic Scaffolds Via Organocatalytic Cycloadditions of α-Imino γ-Lactones and Alkylidene Pyrazolones

Published on: February 7, 2019

7.5K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.6K

Related Concept Videos

Five-Membered Heterocyclic Aromatic Compounds: Overview01:13

Five-Membered Heterocyclic Aromatic Compounds: Overview

Heterocyclic aromatic compounds are cyclic compounds that are aromatic and have one or more heteroatoms—atoms other than carbon, in the ring. Depending upon the number of atoms present in the ring, they can be either five or six-membered. Examples of five-membered heterocyclic aromatic compounds include pyrrole, furan, thiophene, and imidazole. Pyrrole consists of one nitrogen atom having one lone pair of electrons. Furan and thiophene have one oxygen and one sulfur heteroatom,...
6.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.2K
Aromatic Hydrocarbon Cations: Structural Overview01:18

Aromatic Hydrocarbon Cations: Structural Overview

Cycloheptatriene is a neutral monocyclic unsaturated hydrocarbon that consists of an odd number of carbon atoms and an intervening sp3 carbon in the ring. The three double bonds in the ring correspond to 6 π electrons, which is a Huckel number, and therefore satisfies the criteria of 4n + 2 π electrons. However, the intervening sp3 carbon disrupts the continuous overlap of p orbitals. As a result, cycloheptatriene is not aromatic.
Removing one hydrogen from the intervening CH2 group...
4.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.5K